Of interest, OLFM3 was recently identified, and independently replicated, in an ultra‐deep CSF proteomics study as a novel AD biomarker, in addition to being elevated in both MCI and AD post‐mortem human brain samples.57 The gene discussed is OLFM3; the disease is Alzheimer disease.